KENNETH FORE: Open Payments
NPI 1407059637 · PORTSMOUTH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 12 payments from 6 companies in 2025. Trend: 2023 $1,139 · 2024 $777 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $82 |
| Alkermes, Inc. | 3 | $71 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: ARISTADA, HETLIOZ, Auvelity, TRINTELLIX, REXULTI, FANAPT, CAPLYTA.
Industry payments across VA — which companies pay providers there.
